B7-H3 CAR-T cells effectively controlled tumor progression in both HT29 and HCT116 derived metastatic xenografts, with 66.67% (10/15) of HT29 and 66.67% (6/9) of HCT116 inoculated mice remained tumor-free at the endpoint of observation. The gene discussed is CD276; the disease is neoplasm.